Jubilant Ingrevia Q2'FY27 Results: PAT Surges 61% YoY Alongside ZettaOne Acquisition
Jubilant Ingrevia Ltd · Press Release · 27 Oct 2026, 8:19 pm
Jubilant Ingrevia Q2'FY27 Results: PAT Surges 61% YoY Alongside ZettaOne Acquisition Jubilant Ingrevia reported strong Q2'FY27 performance on 27th Oct'26, with revenue rising 24% YoY to an all-time high of ₹1,394 crore. EBITDA surged 51% YoY to ₹221 crore, expanding margins to 16%, while PAT rose 61% YoY to ₹111 crore. Growth was led by Chemical Intermediates (EBITDA up 226% YoY) and Nutrition & Health Solutions (EBITDA up 87% YoY). The company also announced a 40% strategic stake acquisition in ZettaOne Technologies for ₹189.2 crore to enter the electronics and semiconductor EDMS space.
Original exchange filing (PDF)
More announcements from Jubilant Ingrevia Ltd
- Management of the Company will be participating in Kotak Midcap Conference 2026 scheduled on 26th & 27th November, 2026 · 17 Nov 2026
- Update on acquisition of Strategic Equity Stake in Zettaone Technologies India Private Limited · 09 Nov 2026
- Transcript of the Investors'' Conference Call for un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, held on October 27, 2026 · 02 Nov 2026
- Pursuant to Regulations 30 of the SEBI Listing Regulations, we wish to inform that audio recording of investors' Conference Call for un-audited financial results for the quarter and half .... · 28 Oct 2026
- Resignation of SMP · 27 Oct 2026
- Press Release & Investor Presentation · 27 Oct 2026
- Outcomes of the Board Meeting · 27 Oct 2026
- Approval for grant of ESOPs · 27 Oct 2026
